Search
for
Sort by
Research 901–930 of 1000+
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Comprehensive single-cell transcriptomic profiling of the scalp from patients with moderate-to-severe alopecia areata
- Clinical characteristics, subtype classification, and prognostic factors of ophiasis: A retrospective study of 150 patients with therapeutic implications
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- The Economic Burden of Alopecia Areata: Evidence from a Survey in Norway and Sweden
- Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations
- Stem cell-based therapies for alopecia areata: a narrative review
- Towards cell-based therapy of alopecia areata: Autologous human Vδ2+ Foxp3+ γδTreg cells restore hair-follicle immune privilege and promote hair regrowth in human alopecia areata models ex vivo and in vivo
- Hematological ratios in pediatric patients with alopecia areata based on a nationwide retrospective cohort study
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- Alopecia Areata
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Exosome-Based Therapies for Alopecia Areata: A Systematic Review of Clinical and Experimental Evidence
- Economic Burden of Alopecia Areata in the Kingdom of Saudi Arabia from a Societal Perspective: A Cost-of-Illness Analysis
- Inflammatory Skin Disease in Latin America: Treatment Challenges and Opportunities
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Treatment Survival and Reasons for Discontinuation in Patients with Recalcitrant Folliculitis Decalvans
- T <sub>H</sub> 1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Real-world evidence in alopecia areata treatment: A narrative review
- Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations
- Genetic Insights into Acne, Androgenetic Alopecia, and Alopecia Areata: Implications for Mechanisms and Precision Dermatology
- Unlocking the Potential of Rosemary in Alopecia: A Narrative Review of Evidence on Mechanism, Applications and Challenges
- Review of Promising Off-Label Use of Deucravacitinib
- Global sex disparities in lifetime risk of alopecia areata: a systematic analysis from the global burden of disease study, 1990 to 2021
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- SLE classification criteria item relationships: implications on SLE as a disease entity
- Development and Evaluation of Nanoemulgel Loaded with Minoxidil